Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· The Science of Skin PodcastAudio language not provided

Rapamycin slowed aging signs in nine of ten organs in middle-aged mice

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

In the described clip, Dr. Rich Miller says his lab examined ten organs in middle-aged mice and found slower aging in nine of ten with rapamycin, suggesting it slows aging itself rather than only preventing cancers that often kill lab mice. [1]

  1. Dr. Rich Miller's lab examined ten different organs in middle-aged mice for signs of aging instead of only tracking lifespan. [1]

  2. Nine out of ten organs showed slower aging with rapamycin. [1]

  3. The creator presents this as a sign that rapamycin slows aging itself, not just the cancers that often kill lab mice. [1]

Miller's lab tested organ aging, not just lifespan

The description presents rapamycin as the most famous longevity drug from aging research and asks whether it is really just a strong anti-cancer treatment in disguise. To test this directly, Dr. Rich Miller explains, his lab did not only track lifespan. Instead, it examined ten different organs in middle-aged mice for signs of aging. [1]

Nine of ten mouse organs aged more slowly

According to the description, nine out of ten organs showed slower aging with rapamycin. The creator presents this as a strong sign that rapamycin is genuinely slowing the aging process itself, not just preventing the cancers that often kill lab mice. [1]

Mouse findings in a short educational clip

The described work concerns middle-aged mice, not people, and the description gives no human outcome. It reports no sample size, dose, duration or statistical measure. The clip is described as educational only and not as diagnosis, treatment or medical advice. [1]

Context & limits

Only the video description was reviewed; the video and transcript were not reviewed. The description reports no sample size, dose, treatment duration or statistical measure, and the findings concern middle-aged mice, not human lifespan or health.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Rapamycin slows aging in mice
Quoted passages in the original language
examined ten different organs in middle-aged mice
Nine out of ten showed slower aging
not just preventing the cancers that often

About this video

Creator description · original textText language: English

Rapamycin is the most famous longevity drug to come out of aging research — but is it just a great anti-cancer treatment in disguise? Dr. Rich Miller explains how his lab tested this directly: instead of just tracking lifespan, they examined ten different organs in middle-aged mice for signs of aging. Nine out of ten showed slower aging with rapamycin — a strong sign it's genuinely slowing the aging process itself, not just preventing the cancers that often kill lab mice. Disclaimer: This clip is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment. #Rapamycin #Longevity #AgingResearch #HealthyAging #Biohacking

The Science of Skin Podcast · 2 min · Source published: 2026-09-23

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…